Year: 2025

Medical Care Technologies Inc. (OTC PINK:MDCE) Accelerates Growth Trajectory as Its Diverse AI Ecosystem Eyes $450 Billion in Multi-Market Potential

MESA, ARIZONA / ACCESS Newswire / October 14, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) today announced that its...

Red Light Holland Secures Second United States Controlled Substances Import Permit for the Company’s Psilocybin Through FDA-Compliant, DEA-Registered Partner Irvine Labs

Red Light Holland granted Second DEA Import Permit through Irvine Labs for expanded psilocybin research programThis United States Controlled Substances...

Celularity Announces Peer-Reviewed Publication of Phase 2 Clinical Trial Results Demonstrating the Safety and Efficacy of Human Placenta-Derived Cells (PDA-002) for Diabetic Foot Ulcers Complicated by Peripheral Artery Disease

First-in-class regenerative therapy for diabetic foot ulcers complicated by peripheral artery diseaseCelularity PDA-002 achieved durable wound healing with just two...

Telomir Pharmaceuticals Announces New Data Showing That Telomir-1 Kills Aggressive Pancreatic Cancer Cells, One of the Deadliest Forms of Cancer

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1's consistent impact on cancer...

Cellectar Biosciences Presented Promising Preclinical Data in Poster Presentation at the American Association for Cancer Research (AACR) Special Conference on Pancreatic Cancer Research

CLR 225 (225Ac-phospholipid ether) Demonstrates Meaningful Inhibition of Tumor Growth and Potential Survival Benefit In Three Pancreatic Cancer Xenograft ModelsFLORHAM...

error: Content is protected !!